DiversifyRx

FEBRUARY 13, 2025

For independent pharmacies, its an opportunity to: Educate your community : Many patients dont fully understand the range of services pharmacies offer, such as compounding, point-of-care testing, or functional medicine consultations. The post Pharmacy Marketing: Top Blogs of 2024 first appeared on DiversifyRx.

Independent Pharmacies

Omnicell

JANUARY 10, 2023

Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.

Sterile Compounds

Omnicell

SEPTEMBER 5, 2022

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

Sterile Compounds

Omnicell

SEPTEMBER 5, 2022

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

Sterile Compounds

Omnicell

JANUARY 10, 2023

So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Dave has been a leader in adoption of IV automation and will share how IV compounding robot and iv workflow solutions are improving safety and helping to reduce errors across all areas of sterile compounding.

Sterile Compounds

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding

Omnicell

FEBRUARY 17, 2023

Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. Our engineering team scoured through design ideas and broke down all the compounded activities into individual tasks. Subscribe today.

Omnicell

Omnicell

SEPTEMBER 5, 2022

When we talked about IV room compounding, I’ll never forget them telling me, “Making IVs is not like making pizzas at the local sub shop.” ” It’s not a big deal if you mix up sausage and pepperoni on a pizza, but one misstep in manual IV compounding could be absolutely devastating to a patient.

Compounding

Omnicell

SEPTEMBER 5, 2022

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

Sterile Compounds

Omnicell

JANUARY 10, 2023

Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs). Subscribe today.

Compounding

Omnicell

JANUARY 10, 2023

Implementing an intelligent infrastructure of automation and intelligence, supported by expert services to ensure optimization, is an opportunity for health systems to enhance medication distribution processes, support sterile compounding safety and efficiency, and ultimately improve pharmacy supply chain management. Subscribe today.

Sterile Compounds

Omnicell

JANUARY 10, 2023

See how Omnicell is transforming pharmacy care at Booth #1213 in the Exhibit Hall, where you can explore our full portfolio of services for central pharmacy and IV compounding robotics, point-of-care dispensing, inventory optimization, specialty pharmacy, and retail pharmacy. ASHP Midyear is more than a meeting. Subscribe today.

Specialty Pharmacies

The FDA Law Blog

FEBRUARY 28, 2023

THC acetate esters are different than delta-9-THC, the psychoactive compound found naturally in the cannabis plant. Dr. Boos explained that delta-9-THCO and delta-8-THCO have similar chemical structures and pharmacological activities as compounds in the cannabis plant so they fall within the definition of THC. Terrence L. Boos, Ph.D.,

Controlled Substances

IDStewardship

APRIL 16, 2023

In 2016 a pharmacy professor developed a blog post about five reasons why people fail the NAPLEX. Now years later, he revisits the topic here. Authored By: Christopher Bland, Pharm.D., BCPS, FIDSA Article Posted 17 April 2023 The NAPLEX is an examination pharmacists take to become licensed.

Compounding

The Honest Apothecary

APRIL 24, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. “Right now, 48 out of 50 State Boards of Pharmacy do not regulate flavoring as compounding. “Right now, 48 out of 50 State Boards of Pharmacy do not regulate flavoring as compounding.

Compounding

The Happy PharmD

JULY 4, 2024

Are you considering a career in compounding pharmacy? Let me take you on a journey into the world of compounding pharmacists, where we dive into everything from job satisfaction to salary expectations. In terms of demand, the future looks promising for compounding pharmacists.

Compounding Pharmacies

Pharmacy Is Right For Me

JULY 23, 2024

This camp gave me a real taste of what being a pharmacist entails as I compounded medications and completed various patient care simulations. It was my first visit to a pharmacy school, and I immediately fell in love with the campus. The week at camp was filled with fun and learning.

Compounding

Board Vitals - Pharmacist

OCTOBER 23, 2024

Testing of the urine or serum of this infant will likely reveal an elevated level of which compound? Testing of the urine or serum of this infant will likely reveal an elevated level of which compound? appeared first on BoardVitals Blog. A 4-week-old infant is brought to the pediatrician for discolored urine.

Medical Schools

Omnicell

JANUARY 10, 2023

The global pharmaceutical robotics market is growing fast than ever, with a projected compounded annual growth over the next five years of more than 13 percent. With the pandemic, many healthcare leaders have realized the advantages of the benefits of automation. Visit Omnicell at booth #5767 during HIMSS22 , March 14-18 in Orlando.

Omnicell

ISPE

APRIL 13, 2023

For example, process simulators can report model-based air emissions such as volatile organic compounds (VOCs) with great accuracy since they are grounded in robust physical properties calculations, like activity coefficient models, that are embedded in the simulators. These calculations are then shared with the environmental agencies.

Compounding

Omnicell

JANUARY 10, 2023

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Omnicell's IV compounding robot service offered the holistic solution we needed.

Sterile Compounds

The FDA Law Blog

JANUARY 22, 2024

Some takeaways on those efforts that we gleaned from the report: Compounding. OC devoted a lot of resources to its compliance efforts directed at human drug compounding. Drug Supply Chain. Communication in this area included on-line videos, webinars, summits, conferences, and international outreach.

Compounding

Digital Pharmacist

DECEMBER 22, 2022

In this blog, we will discuss pharmacy trends to look out for in 2023 so your business can be as prepared as possible in the New Year. For pharmacies, it is important to understand the needs of the patients, and the services that patients are looking for so patient expectations can not only be met but exceeded. .

Community Pharmacies

Omnicell

SEPTEMBER 5, 2022

The operational blind spots caused by disconnected, siloed systems compounded by the delays and errors caused by outdated manual workflows are the hallmarks of operational complexity that impedes ideal perpetual inventory management and leads to financial strains that plague pharmacies.

Controlled Substances

The Thyroid Pharmacist

JUNE 30, 2023

Interview With Dr. Mark Mandel To learn more, I decided to interview Dr. Mark Mandel, PharmD, compounding pharmacist, LDN expert, and fellow Midwestern University Chicago College of Pharmacy grad, on the effects of LDN in people with Hashimoto’s and autoimmunity. The transdermal formulation is recommended for children with autism.

Compounding

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.

Sterile Compounds

Omnicell

JANUARY 10, 2023

IV compounding automation and robust services that include access to low cost cGMP stability studies to support extended beyond use dating. DISCLAIMER The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company.

Omnicell

ISPE

MAY 16, 2023

ISPE GAMP® Blockchain Special Interest Group Trudy Patterson Tue, 05/16/2023 - 10:24 iSpeak Blog iSpeak ISPE GAMP® Blockchain Special Interest Group James Canterbury Tanya Sharma 16 May 2023 The ISPE GAMP ® Blockchain Special Interest Group is excited to be in its 4th year! from 2021 to 2028.

Compounding

DiversifyRx

JANUARY 31, 2024

Ditch your dependence on PBMs and grow your non-PBM revenue with this review of our top 2023 blogs. Let’s recap the most popular 2023 blog posts that spotlight non-PBM revenue. 5 Proven Strategies for Growing Your Compounding Pharmacy – Top 5 tried-and-true strategies to grow your compounding pharmacy.

Independent Pharmacies

The FDA Law Blog

AUGUST 8, 2023

Perhaps most importantly, the guidance concludes with examples of how manufacturers would apply this framework to Nitroso compounds. All of these deviations discussed in FDA inspectional observations and Warning Letters have caused serious issues for manufacturers of APIs or finished drug products.

FDA

Omnicell

JANUARY 10, 2023

In the central pharmacy, our IVX Workflow management system , now supports decentralized compounding, enabling an sterile compounding workflow system now supports decentralized compounding, enabling an alternative way to compound new orders. Learn more about these latest innovations here.

Controlled Substances

The FDA Law Blog

JULY 5, 2023

As a reminder, in Title I of the 2013 Drug Quality and Security Act (DQSA) (the Compounding Quality Act), Congress created the “outsourcing facility” FDA registration category, and set forth statutory parameters for their operation in new section 503B of the FDCA. 353b(a)(8). 353b(a)(8). the wholesale distributor, repackager, relabeler).

Compounding

ISPE

MARCH 16, 2023

In this blog, we will briefly explore the challenges and opportunities of digitalized aseptic production, fully contained and automated production and collaborative work with CMOs. ISPE Good Practice Guide on Containment for Potent Compounds 4. Current and future good practices from an owner’s & engineer’s perspective.

Pharmaceutical Companies

The Pharmacist Blog

MARCH 24, 2015

Compound interest is the eighth wonder of the world. As a Pharmacy Technician the compound interest just snowballs with more years to build. Follow my blog for more tips and advice on finances and being a pharmacist. appeared first on The Pharmacist Blog. Why is this you may ask? – Albert Einstein.

Compounding

The FDA Law Blog

SEPTEMBER 11, 2024

FDA says that highly potent compounds – again, as defined in ICH M7(R2) – pose risks below that limit. Using the guidelines found in the ICH M7(R2) , FDA set an AI threshold of 1.5 micrograms per day “for any unstudied chemical that poses a negligible risk of carcinogenicity or other toxic effects.”

FDA

Roots Analysis

MARCH 15, 2023

In fact, high throughput flow cytometers are used for phenotypic screening, antibody screening, lead optimization and multiplex compound profiling, enabling the measurement of several endpoints at once.

Compounding

DiversifyRx

JANUARY 4, 2024

Let’s get you caught up with the best independent pharmacy cash-based revenue opportunities in 2023 with our most popular blogs. To ensure you stay ahead of the curve, we’re recapping our most popular 2023 blogs for each Pharmacy Profit Pillar, and we are starting with pharmacy cash-based revenue.

Independent Pharmacies